JPWO2023162946A5 - - Google Patents

Info

Publication number
JPWO2023162946A5
JPWO2023162946A5 JP2024503152A JP2024503152A JPWO2023162946A5 JP WO2023162946 A5 JPWO2023162946 A5 JP WO2023162946A5 JP 2024503152 A JP2024503152 A JP 2024503152A JP 2024503152 A JP2024503152 A JP 2024503152A JP WO2023162946 A5 JPWO2023162946 A5 JP WO2023162946A5
Authority
JP
Japan
Prior art keywords
formula
indicates
group
integer
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503152A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023162946A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/006110 external-priority patent/WO2023162946A1/ja
Publication of JPWO2023162946A1 publication Critical patent/JPWO2023162946A1/ja
Publication of JPWO2023162946A5 publication Critical patent/JPWO2023162946A5/ja
Pending legal-status Critical Current

Links

JP2024503152A 2022-02-22 2023-02-21 Pending JPWO2023162946A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022026194 2022-02-22
PCT/JP2023/006110 WO2023162946A1 (ja) 2022-02-22 2023-02-21 放射標識されたＦＡＰα親和性化合物およびその用途

Publications (2)

Publication Number Publication Date
JPWO2023162946A1 JPWO2023162946A1 (https=) 2023-08-31
JPWO2023162946A5 true JPWO2023162946A5 (https=) 2026-01-27

Family

ID=87765897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503152A Pending JPWO2023162946A1 (https=) 2022-02-22 2023-02-21

Country Status (4)

Country Link
EP (1) EP4483905A1 (https=)
JP (1) JPWO2023162946A1 (https=)
AU (1) AU2023223808A1 (https=)
WO (1) WO2023162946A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118388451A (zh) * 2024-06-28 2024-07-26 四川大学 一种放射性标记的成纤维细胞活化蛋白抑制剂及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018312327B2 (en) * 2017-08-04 2022-05-12 Osaka University Production method for radiolabeled aryl compound
EA202090776A1 (ru) 2017-10-23 2020-07-27 Дзе Джонс Хопкинс Юниверсити Визуализирующие и радиотерапевтические агенты, нацеленные на фибробласт-активирующий белок-альфа (fapalpha)
EP3749663A1 (en) * 2018-02-06 2020-12-16 Universität Heidelberg Fap inhibitor
GB201801882D0 (en) 2018-02-06 2018-03-21 Apollo Tyres Global R & D Bv Rubber composition for tyres with good wet grip and rolling resistance properties
CZ309380B6 (cs) * 2020-03-30 2022-10-26 Ústav organické chemie a biochemie AV ČR v. v. i Sloučeniny pro inhibici fibroblastového aktivačního proteinu
JP7693288B2 (ja) 2020-07-30 2025-06-17 株式会社Ｄｎｐ高機能マテリアル彦根 熱交換器
CN112023064A (zh) * 2020-11-03 2020-12-04 南京大为科创服务有限责任公司 用于标记核素211At的成纤维细胞活化蛋白抑制剂的锡基衍生物及其制备方法和应用

Similar Documents

Publication Publication Date Title
EP3417883B1 (en) Targeted alpha-particle emitting complexes comprising thorium radionuclide and hydroxypyridinone containing ligand
JP2021510698A5 (https=)
CN102266288B (zh) 一种基于胆固醇修饰的还原敏感性肿瘤靶向脂质体
CN101668547B (zh) 选择缺氧组织的弱碱性2-硝基咪唑递送剂及其应用方法
KR20230129261A (ko) 섬유모세포 활성화 단백질 리간드를 포함하는 화합물및 그의 용도
TWI654179B (zh) 放射性醫藥複合物
CN110357967B (zh) 新型成像组合物及其用途
JPH02501141A (ja) テトラ‐アザ大環状化合物およびその金属錯体
CN115210240A (zh) 化合物及放射性标记化合物
JPWO2023162946A5 (https=)
CN120225228A (zh) 成纤维细胞激活蛋白(fap)抑制剂、fap缀合物及其诊断和治疗用途
RU2012114146A (ru) Нерадиоактивные фосфолипидные соединения, композиции и способы их применения
CN116554146A (zh) 一种FAP-α特异性放射性药物及其应用
WO2007104135A1 (en) Bifunctional polyazamacrocyclic chelating agents
US11426395B2 (en) PSMA inhibitor derivatives for labelling with 99mTc via HYNIC, a radiopharmaceutical kit, radiopharmaceutical preparations and their use in prostate cancer diagnostics
CN118812491A (zh) 一种pd-l1小分子抑制剂及其制备方法和应用
Huang et al. Advancing cancer therapy with a heptamethine carbocyanine dye-conjugated radionuclide drug
RU2812633C1 (ru) Комплекс технеция-99м с рекомбинантными адресными молекулами белковой природы с анкириновыми повторами для радионуклидной диагностики злокачественных образований с гиперэкспрессией her2/neu и способ его получения
US20260083865A1 (en) Prostate specific membrane antigen (psma) ligands and use thereof
CN119101100B (zh) 一种放射性核素药物及其制备方法和应用
EP4435060A1 (en) Silicon phthalocyanine and tribenzophthalocyanine dyes and their use in diagnosis and therapy
Nakashima et al. Control of pharmacokinetics of radioimmunoconjugates using chelating agents containing poly (ethylene glycol)
CN120136960A (zh) 一种成纤维细胞活化蛋白靶向化合物、其核素标记物、包含其的药物组合物和应用
CN117379569A (zh) 一种核素标记的靶向dna双链断裂探针及其制备方法和应用
HK40078050A (en) Compound and radioactive labeling compound